Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

LCT files pericyte protective agent provisional patent

LCT files pericyte protective agent provisional patent

7 November 2017 – Sydney, Australia & Auckland, New Zealand – Living Cell Technologies Limited has filed a provisional patent for pericyte protective agents titled “PERICYTE PROTECTIVE AGENTS FOR NEUROLOGICAL DISORDERS INCLUDING NEURODEGENERATIVE DISEASES, CENTRAL NERVOUS SYSTEM DISEASES AND OTHERS”.

The invention in this provisional patent arises from LCT’s research collaboration with the Centre for Brain Research (CBR) at The University of Auckland. The research collaboration explored how LCT’s products can reverse human brain neurodegenerative processes associated with pericytes (and other brain cells), which help sustain the blood-brain barrier and other homeostatic and haemostatic functions in the brain.

The project had two primary goals. The first was to extend the pipeline for LCT’s lead product NTCELL® by examining the effects of NTCELL on cell cultures derived from human brains with Alzheimer’s disease and Parkinson’s disease. The second was to identify neuroactive constituents of NTCELL and their site of action.

The research was undertaken by Auckland UniServices Limited (UniServices), the commercial research company of The University of Auckland, using the breakthrough drug testing and drug target validation platform, Neurovalida. Neurovalida, developed by Professor Mike Dragunow, Distinguished Professor Sir Richard Faull and Associate Professor Maurice Curtis from the CBR, provides human brain-based neuroscience research collaborations, partnerships and services.

CEO of Living Cell Technologies, Dr Ken Taylor, says he is delighted that the project using CBR’s world class capabilities has resulted in the filing of this provisional patent.

“This will enable LCT to build and extend its expertise on the efficacy of cell therapies which have the potential to treat neurodegenerative disorders. Most important is the ability to generate data from human brain tissue cultures in vitro to lead us to the identification of neuroprotective product candidates.”

Director of the CBR, Distinguished Professor Sir Richard Faull, says he pleased that the project outcome has been so successful.

“The team at the Centre for Brain Research is proud to be part of this collaboration researching disease modifying treatments for Parkinson’s, Alzheimer’s and other neurodegenerative diseases.

“This is a great example of translational neuroscience,” he added.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

BusinessDesk: Body massages and Uber are in, DVDs are out, says Stats NZ

Statistics New Zealand has rejigged the consumers price index basket in its latest three-year review, adding body massages, Airbnb and Uber and removing DVD and Blu-Ray players…More>>

ALSO:


StuffMe: Commerce Commission Welcomes Dismissal Of Merger Appeal

In a summary of their judgment released today, Justice Dobson and lay member Professor Martin Richardson dismissed the appellants’ process criticisms and found the Commission was entitled to place significant weight on the prospect of reduced quality of the products produced by the merged entity. More>>

ALSO:

Digital Futures: New Chief Technology Officer Role Created

Communications Minister Clare Curran has called for expressions of interest for the new role of Chief Technology Officer position to help drive a forward-looking digital agenda for New Zealand. More>>

Real Estate: NZ house sales slump in December but prices still firm

The number of property sales across New Zealand slumped 10 percent in December from a year earlier but prices continued to lift, according to the Real Estate Institute. More >>

ALSO:


Dry: Beef + Lamb Launches Drought Resources

The resources include a fact sheet outlining strategies to manage and mitigate the effects of drought, coping with stress on the farm and advice on feed requirements and animal welfare during the dry period. More>>

ALSO:

InternetNZ: Net Neutrality Failure In US "Will Hurt All Users"

InternetNZ Chief Executive Jordan Carter has condemned the decision by the United States communications regulator to undo 2015 open Internet rules, warning that all Internet users will end up worse off as a result. More>>

ALSO: